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Erratum to: Perfusion Pressure Cerebral
Infarct (PPCI) trial - the importance of mean
arterial pressure during cardiopulmonary
bypass to prevent cerebral complications




Unfortunately, the original version of this article [1]
contained an error. The listings “Excusion criteria” and
“Inclusion criteria” are incorrect. The bullet point
“Contractions to magnetic resonance imaging (MRI)”
should be listed under "Exclusion criteria" and not under
"Inclusion criteria". The correct listing can be found
below:
Inclusion criteria
Patients included in the trial are as follows:
 ≥18 years of age
 Scheduled for elective or subacute cardiac surgery
with the use of CPB
 Scheduled for CABG and/or heart valve surgery
Exclusion criteria
Patients fulfilling one or more of the following criteria
will not be included:
 A history of stroke or intracranial bleeding
 A history of reversible ischaemic deficits (duration
of symptoms 24–72 hours)
 A history of transient ischaemic attacks (duration of
symptoms < 24 hours)
 Diagnosis of neurodegenerative disorders such as
Alzheimer’s, multiple sclerosis etc.
 Contraindications to magnetic resonance imaging
(MRI)
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